title: Inhaled steroids in COPD: when should they be used?
authors.affiliation: Thorax Institute, Hospital Clinic, IDIBAPS, University of Barcelona, CIBERES, Spain. Electronic address: alvar.agusti@clinic.ub.es.
authors.forename: Alvar
authors.initials: A
authors.lastname: Agusti
authors.affiliation: Section of Respiratory Diseases, Department of Oncology, Hematology and Respiratory Diseases, University of Modena and Reggio Emilia, Modena, Italy.
authors.forename: Leonardo M
authors.initials: LM
authors.lastname: Fabbri
mesh_terms: D000280:Administration, Inhalation; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use*; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D001993:Bronchodilator Agents / Q000627:therapeutic use*; D000075202:Contraindications; D004359:Drug Therapy, Combination; D005541:Forced Expiratory Volume; D006801:Humans; D029424:Pulmonary Disease, Chronic Obstructive / Q000188:drug therapy* / Q000503:physiopathology
chemical_list: D000305:Adrenal Cortex Hormones; D000893:Anti-Inflammatory Agents; D001993:Bronchodilator Agents